pancreatitis glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes american diabetes association history of

The growing popularity of GLP-1 receptor agonistsincluding Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound from Eli Lillyhas added fuel to an already fiery debate over the governments

The promise of #GLP-1 receptor agonists for #neurodegenerative diseases Dilan Athauda @DilanAthauda et al

Take just 1 easy to swallow mini tablet to support weight loss journey by filling key nutrient gaps arising from a low calorie diet*

To help people figure out who qualifies, whats involved and what to expect for first-time GLP-1 users, a pair of weight management specialists at MUSC Health sat down for this Q&A.

Future research should focus on longitudinal dietary assessment, biomarker monitoring, and validation of standardized nutrition protocols for patients receiving GLP1-based obesity pharmacotherapy.